presented by TOWER
BY INVITATION ONLY
UNDERVALUED NO MORE: THE INVESTMENT CASE FOR WOMEN'S HEALTH
A Private Evening with Author & CEO Marissa Fayer
In Conversation with Sanskriti Thakur, Founder & Chairwoman, TOWER
July 16, 2026 | TOWER HQ, New York City
TOWER is proud to host an intimate evening celebrating the launch of Undervalued to Unavoidable: Women's Health as Infrastructure — the new book by Marissa Fayer that reframes women's health not as a cause to champion, but as a structural investment opportunity the world can no longer afford to ignore.
As the global pioneer of Generational Health, TOWER believes the decisions made about women's health today determine the outcomes experienced across generations. Marissa’s new book makes that case with the data, the urgency, and the playbook to act on it.
This is not a book written about the women's health crisis from the outside. Marissa Fayer has spent more than 25 years inside the companies, boardrooms, and investment committees where the decisions get made — and watched too many of them get made badly, for reasons that had nothing to do with the data. Undervalued to Unavoidable is the investment case and playbook she has been building the argument for her entire career.
The numbers make the case that advocacy never could. Nearly $1 trillion lost annually to the global cost of women's ill health. A 9:1 return on every dollar invested in women's and children's health. A FemTech market projected to exceed $100 billion by 2030. This isn't ideology. It's systems logic. And the early movers will define the category.
ABOUT MARISSA FAYER
Marissa Fayer is not a policy commentator or an academic researcher. She is an operator with more than 25 years inside the companies, boardrooms, and investment committees where decisions about women's health actually get made — and she has watched too many of them get made badly, for reasons that had nothing to do with the data.
She spent the first 15 years of her career inside medical device companies including Hologic, Olympus, and Maquet — designing and commercializing the equipment that screens, diagnoses, and treats the conditions women face. Her work took her across North America and Latin America, giving her a front-row seat to how "access" looks completely different depending on which side of a hemisphere you're standing on.
She has raised capital, navigated FDA clearances, sat on investment committees, and built distribution channels on five continents.
She is the founder of HERhealthEQ, a global nonprofit now operating in 12 countries that has reached over 135,000 women by redirecting medical equipment classified as waste in the U.S. to healthcare systems where women are dying for lack of technology sitting in a storage facility somewhere. The organization was born not as a grand philanthropic vision, but as an engineer's response to a solvable problem.
She is also the CEO of DeepLook Medical, an AI diagnostics company that detects breast cancer earlier in women with dense breast tissue. She sits on investment committees and corporate boards where the funding decisions actually get made.
Marissa wrote the book she wished had existed 25 years ago. On June 11, she brings that conversation to TOWER — one day after one of the most significant announcements of her career.
Copyright 2026. Tower Capital Group LLC. All Rights Reserved
Important Disclosures and Disclaimers
This document is for informational purposes only and is intended exclusively for the use of the persons to whom it is delivered and the information provided therein is confidential and may not be reproduced in its entirety or in part, or redistributed to any party in any form, without the prior written consent of TOWER Capital Group, LLC, or any named affiliate entity (“TOWER” or “TOWER Capital”). Information contained in this document is current only as of the date specified in the document, regardless of the time of delivery or of any investment, and TOWER does not undertake any duty to update the information set forth herein.
Certain information included in this document is based upon information reasonably available to TOWER. Furthermore, the information included in this document has been obtained from sources TOWER believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained in this document and no liability is accepted for the accuracy or completeness of any such information. TOWER maintains historical materials and disclosures in this document for archival and regulatory purposes. The information contained in such materials and disclosures is believed to be reliable at the time it is initially presented, and TOWER assumes no responsibility for updating information to reflect subsequent developments. Any transactions highlighted within investment updates in this material are not representative of the entire investment portfolio and there is no guarantee that other investments or transactions in the portfolio not described herein are/will be successful. For additional important disclosures and notices, please review our Notices page at www.towercapital.org/notices.